Literature DB >> 35034321

Coronary revascularisation outcome questionnaire: validation study of the Serbian version.

Nemanja Aleksic1, Svetozar Putnik1, Sara Schroter2, Vedrana Pavlovic3, Uros Bumbasirevic4, Mina Zlatkovic1, Ilija Bilbija1, Milos Matkovic1, Aleksa Jovanovic5, Tatjana Pekmezovic5, Gorica Maric6.   

Abstract

PURPOSE: To translate, culturally adapt and validate the Coronary Revascularisation Outcome Questionnaire (CROQ), a disease-specific tool for measuring health-related quality of life (HRQoL) in patients with ischaemic heart disease (IHD), into Serbian language (CROQ-S).
METHODS: Validation study was performed at the Clinic for Cardiac Surgery and Clinic for Cardiology, University Clinical Centre of Serbia. We included a convenience sample of 600 patients with IHD divided into four groups. Acceptability, reliability and validity of the CROQ-S were assessed.
RESULTS: CROQ-S was acceptable to patients as demonstrated by less than 1% of missing data for each single item. Cronbach's Alpha was higher than the criterion of 0.70 for all scales in each version except the Cognitive Functioning scale which only met this criterion in the CABG pre-revascularisation version. Mean values of item-total correlations were greater than 0.30 for all scales except the Cognitive Functioning scale in both the pre-revascularisation groups. Compared to the original version, exploratory factor analysis in our study showed more factors; however, the majority of items had a factor loading greater than 0.3 on the right scale. Correlations of CROQ-S scales with the 36-Item Short Form Health Survey and Seattle Angina Questionnaire showed the expected pattern whereby scales measuring similar constructs were most highly correlated.
CONCLUSION: CROQ-S is an acceptable, reliable and valid disease-specific instrument for measuring HRQoL in this sample of Serbian speaking patients with IHD both before and after coronary revascularisation. However, the Cognitive Functioning scale did not meet all the psychometric criteria and further validation of its responsiveness is required.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Coronary artery bypass surgery; Health-related quality of life; Ischaemic heart disease; Patient-reported outcome measure; Percutaneous coronary intervention

Mesh:

Year:  2022        PMID: 35034321     DOI: 10.1007/s11136-021-03064-0

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  23 in total

1.  Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.

Authors:  Niels R Holm; Timo Mäkikallio; M Mitchell Lindsay; Mark S Spence; Andrejs Erglis; Ian B A Menown; Thor Trovik; Thomas Kellerth; Gintaras Kalinauskas; Lone Juul Hune Mogensen; Per H Nielsen; Matti Niemelä; Jens F Lassen; Keith Oldroyd; Geoffrey Berg; Peteris Stradins; Simon J Walsh; Alastair N J Graham; Petter C Endresen; Ole Fröbert; Uday Trivedi; Vesa Anttila; David Hildick-Smith; Leif Thuesen; Evald H Christiansen
Journal:  Lancet       Date:  2019-12-23       Impact factor: 79.321

2.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

3.  Quality of life after coronary angioplasty or bypass surgery. 1-year follow-up in the Coronary Angioplasty versus Bypass Revascularization investigation (CABRI) trial.

Authors:  P Währborg
Journal:  Eur Heart J       Date:  1999-05       Impact factor: 29.983

4.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.

Authors:  Daniel J F M Thuijs; A Pieter Kappetein; Patrick W Serruys; Friedrich-Wilhelm Mohr; Marie-Claude Morice; Michael J Mack; David R Holmes; Nick Curzen; Piroze Davierwala; Thilo Noack; Milan Milojevic; Keith D Dawkins; Bruno R da Costa; Peter Jüni; Stuart J Head
Journal:  Lancet       Date:  2019-09-02       Impact factor: 79.321

5.  Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.

Authors:  Ori Ben-Yehuda; Shmuel Chen; Björn Redfors; Thomas McAndrew; Aaron Crowley; Ioanna Kosmidou; David E Kandzari; John D Puskas; Marie-Claude Morice; David P Taggart; Martin B Leon; Nicholas J Lembo; W Morris Brown; Charles A Simonton; Ovidiu Dressler; Arie Pieter Kappetein; Joseph F Sabik; Patrick W Serruys; Gregg W Stone
Journal:  Eur Heart J       Date:  2019-06-21       Impact factor: 29.983

Review 6.  Comparison of the Postprocedural Quality of Life between Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Intervention: A Systematic Review.

Authors:  Kaneez Fatima; Mohammad Yousuf-Ul-Islam; Mehreen Ansari; Faizan Imran Bawany; Muhammad Shahzeb Khan; Akash Khetpal; Neelam Khetpal; Muhammad Nawaz Lashari; Mohammad Hussham Arshad; Raamish Bin Amir; Hoshang Rustom Kakalia; Qaiser Hasan Zaidi; Sharmeen Kamran Mian; Bahram Kazani
Journal:  Cardiol Res Pract       Date:  2016-02-18       Impact factor: 1.866

Review 7.  Burden and Prevention of Adverse Cardiac Events in Patients with Concomitant Chronic Heart Failure and Coronary Artery Disease: A Literature Review.

Authors:  Louis Lavoie; Hanane Khoury; Sharon Welner; Jean-Baptiste Briere
Journal:  Cardiovasc Ther       Date:  2016-06       Impact factor: 3.023

Review 8.  The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study.

Authors:  Andrew E Moran; Mohammad H Forouzanfar; Gregory A Roth; George A Mensah; Majid Ezzati; Abraham Flaxman; Christopher J L Murray; Mohsen Naghavi
Journal:  Circulation       Date:  2014-02-26       Impact factor: 29.690

Review 9.  Quality of life in patients with coronary heart disease-I: assessment tools.

Authors:  David R Thompson; Cheuk-Man Yu
Journal:  Health Qual Life Outcomes       Date:  2003-09-10       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.